Factors Influencing Hemoglobin Variability and Its Association with Mortality in Hemodialysis Patients
Table 1
Patient characteristics of hemoglobin variability.
Patient characteristics
HA (: 39)
High (: 13)
Target (: 42)
Low (: 37)
LAH (: 16)
LAL (: 22)
% of total (: 169)
23.4
7.6
24.8
21.8
9.4
13
Age (years) (mean ± SD)
54.6 ± 14.0
47.4 ± 8.3
57.8 ± 13.3
51.7 ± 18.3
53.8 ± 12.2
55.2 ± 15.1
Gender (male) (%)
25 (44.7%)
7 (7.6%)
31 (18.3%)
23 (43.6%)
16 (4.7%)
13 (7.6%)
CKD etiology
Diabetes mellitus
3
2
3
4
2
3
Hypertension
6
3
9
7
3
4
PCKD
3
1
3
4
2
3
Unknown etiology
10
2
9
7
3
5
Others
17
5
18
15
6
7
BMI (kg/m2)
23.3 ± 5.5
22.7 ± 3.7
22.4 ± 3.1
21.7 ± 4.8
23.3 ± 4.3
22.4 ± 4.5
Duration of dialysis (years) (mean ± SD)
10.0 ± 5.9
10.2 ± 4.9
9.0 ± 5.7
9.2 ± 5.2
10.0 ± 7.1
5.8 ± 4.7
HA: high-amplitude fluctuation; LAH: low-amplitude fluctuation with high hemoglobin; LAL: low-amplitude fluctuation with low hemoglobin; BMI: body mass index; CKD: chronic kidney disease; PCKD: polycystic kidney disease; SD: standard deviation.
